Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 239.6 INR 0.76% Market Closed
Market Cap: 22.1B INR

Relative Value

The Relative Value of one INDOCO stock under the Base Case scenario is 547.25 INR. Compared to the current market price of 239.6 INR, Indoco Remedies Ltd is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INDOCO Relative Value
Base Case
547.25 INR
Undervaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
64
Median 3Y
1.8
Median 5Y
2.1
Industry
2.6
Forward
1.2
vs History
vs Industry
15
Median 3Y
22.5
Median 5Y
28.1
Industry
21.7
Forward
-86
vs History
80
vs Industry
36
Median 3Y
19
Median 5Y
19.6
Industry
16.7
vs History
vs Industry
28
Median 3Y
68
Median 5Y
42.7
Industry
23.1
vs History
92
vs Industry
36
Median 3Y
2.8
Median 5Y
3.1
Industry
2.2
vs History
96
vs Industry
58
Median 3Y
1.9
Median 5Y
2.2
Industry
2.9
Forward
1.4
vs History
96
vs Industry
67
Median 3Y
2.9
Median 5Y
3.1
Industry
5.5
vs History
9
vs Industry
20
Median 3Y
16.4
Median 5Y
15.4
Industry
13.2
Forward
15.7
vs History
vs Industry
5
Median 3Y
19.3
Median 5Y
19.3
Industry
16.8
Forward
28
vs History
68
vs Industry
33
Median 3Y
21.4
Median 5Y
21.4
Industry
15.9
vs History
vs Industry
2
Median 3Y
-12.8
Median 5Y
-11.3
Industry
19.2
vs History
96
vs Industry
48
Median 3Y
1.7
Median 5Y
2.1
Industry
1.9

Multiples Across Competitors

INDOCO Competitors Multiples
Indoco Remedies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Indoco Remedies Ltd
NSE:INDOCO
22.1B INR 1.3 -20 37.3 -56.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 17 54.9 36.9 39.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
501.5B USD 5.4 20 16.3 21.2
CH
Roche Holding AG
SIX:ROG
259.2B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212.4B GBP 4.9 30.2 108.5 158.7
CH
Novartis AG
SIX:NOVN
207B CHF 4.7 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
253.9B USD 4 13.3 9.5 11.3
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
144.5B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
IN
Indoco Remedies Ltd
NSE:INDOCO
Average P/E: 24
Negative Multiple: -20
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.9
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.3
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Indoco Remedies Ltd
NSE:INDOCO
Average EV/EBITDA: 402.4
37.3
54%
0.7
US
Eli Lilly and Co
NYSE:LLY
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.5
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.5
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Indoco Remedies Ltd
NSE:INDOCO
Average EV/EBIT: 1 881.3
Negative Multiple: -56.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.5
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.2
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.3
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3